Guided Imagery in Hospitalized Pregnant Women
The Effect of Guided Imagery on Anxiety, Depression, and Sleep in Hospitalized Pregnant Women
1 other identifier
interventional
50
1 country
1
Brief Summary
The study will be carried out in two different groups. Participants will be approached after being hospitalized for at least 24 hours. After the pregnant women are evaluated in terms of eligibility criteria for the research, the pregnant women who are eligible will be informed about the research and written informed consent will be obtained from the pregnant women who accept. The random distribution of pregnant women to the study groups will be carried out random.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable pregnancy
Started Apr 2025
Shorter than P25 for not_applicable pregnancy
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 22, 2025
CompletedStudy Start
First participant enrolled
April 28, 2025
CompletedFirst Posted
Study publicly available on registry
April 29, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 28, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
July 28, 2025
CompletedAugust 29, 2025
August 1, 2025
3 months
April 22, 2025
August 25, 2025
Conditions
Outcome Measures
Primary Outcomes (3)
Change in anxiety
The Hospital Anxiety and Depression Scale is a four-point Likert-type scale used to determine the risk, level, and change in severity of anxiety and depression in patients. The scale consists of 14 items; odd-numbered items assess anxiety, and even-numbered items assess depression. For the anxiety subscale, the cut-off score is 10/11. Individuals scoring above this threshold are considered to be at risk. The lowest possible score on the scale is 0, and the highest possible score is 21.
at the beginning of the study, 3 days later
Change in Depression
The Hospital Anxiety and Depression Scale is a four-point Likert-type scale used to determine the risk, level, and change in severity of anxiety and depression in patients. The scale consists of 14 items; odd-numbered items assess anxiety, and even-numbered items assess depression. For the depression subscale, the cut-off score is 7/8. Individuals scoring above this threshold are considered to be at risk. The lowest possible score on the scale is 0, and the highest possible score is 21.
at the beginning of the study, 3 days later
Change in Sleep Quality
The Richard-Campbell Sleep Questionnaire consists of six items that evaluate the depth of night sleep, time taken to fall asleep, frequency of awakenings, duration of wakefulness upon awakening, overall sleep quality, and the level of noise in the environment. Each item is assessed using a visual analog scale ranging from 0 to 100. Scores between 0-25 indicate very poor sleep, while scores between 76-100 indicate very good sleep. As the total score increases, the sleep quality of patients also improves.
at the beginning of the study, 3 days later
Study Arms (2)
Intervention Group
EXPERIMENTALGuided imagery group
Control Group
NO INTERVENTIONControl Group
Interventions
Participants in this group will receive the guided imagery intervention. They will be approached after being hospitalized for at least 24 hours. The guided imagery audio recording will be played for the pregnant women every evening before sleep for three consecutive days.
Eligibility Criteria
You may qualify if:
- Being 18 years of age or older
- Having no difficulties in understanding and speaking Turkish
- Being hospitalized for at least 24 hours
- Being in the second trimester of pregnancy (14-28 weeks)
- Having a medically stable condition
- Experiencing sleep disturbances
- Voluntarily agreeing to take part in the study
You may not qualify if:
- Having a hearing impairment
- Having ongoing severe vaginal bleeding
- Having a diagnosed psychiatric disorder and/or using psychiatric medication
- Having uncontrolled hypertension
- Presence of intrauterine fetal demise
- Premature rupture of membranes (PROM)
- Being in preterm labor
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Aksaray Eğitim Araştırma Hastanesi
Aksaray, Turkey (Türkiye)
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Menekşe Nazlı Aker
Assistant professor
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Assist. Prof.
Study Record Dates
First Submitted
April 22, 2025
First Posted
April 29, 2025
Study Start
April 28, 2025
Primary Completion
July 28, 2025
Study Completion
July 28, 2025
Last Updated
August 29, 2025
Record last verified: 2025-08
Data Sharing
- IPD Sharing
- Will not share